Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells

被引：15

作者：

Araki, Mutsumi ^{[1
]}

Kitayoshi, Misaho ^{[1
]}

Dong, Yan ^{[1
]}

Hirane, Miku ^{[1
]}

Ozaki, Shuhei ^{[1
]}

Mori, Shiori ^{[1
]}

Fukushima, Nobuyuki ^{[2
]}

Honoki, Kanya ^{[3
]}

Tsujiuchi, Toshifumi ^{[1
]}

机构：

[1] Kinki Univ, Fac Sci & Engn, Dept Life Sci, Div Canc Biol & Bioinformat, Higashiosaka, Osaka 5778502, Japan

[2] Kinki Univ, Fac Sci & Engn, Dept Life Sci, Div Mol Neurobiol, Higashiosaka, Osaka 5778502, Japan

[3] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 634, Japan

来源：

GROWTH FACTORS | 2014年 / 32卷 / 3-4期

基金：

日本学术振兴会;

关键词：

Lysophosphatidic acid; LPA receptor-5; malignant fibrous histiocytoma; osteosarcoma; tumor progression; OVARIAN-CANCER CELLS; TUMOR-CELLS; EXPRESSION; MIGRATION; INDUCTION; GENE; PROLIFERATION; BIOLOGY; LPA(3); ROLES;

D O I：

10.3109/08977194.2014.911294

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Lysophosphatidic acid (LPA) is a bioactive lipid that interacts with G protein-coupled LPA receptors (LPA receptor-1 (LPA(1)) to LPA(6)). Here, we investigated the effects of LPA signaling via LPA(5) on cellular functions of sarcoma cells by generating Lpar5 overexpressing and Lpar5 knockdown cells from rat osteosarcoma and malignant fibrous histiocytoma cells, respectively. The cell motility activity of Lpar5 overexpressing cells was significantly lower, while Lpar5 knockdown cells showed high cell motility, compared with respective controls. Gelatin zymography showed that LPA(5) suppressed the activation of matrix metalloproteinase-2. LPA(5) also inhibited the cell motility activity of endothelial cells, correlating with the expression levels of vascular endothelial growth factor genes. These results suggest that LPA signaling via LPA(5) negatively regulates the cellular functions of rat sarcoma cells.

引用

页码：117 / 122

页数：6

共 32 条

[11] Heterogeneous pattern of gene expression in cloned cell lines established from a rat transplantable osteosarcoma lung metastatic nodule [J].

Honoki, K ;

Mori, T ;

Tsutsumi, M ;

Tsujiuchi, T ;

Kido, A ;

Morishita, T ;

Miyauchi, Y ;

Dohi, Y ;

Mii, Y ;

Tamai, S ;

Konishi, Y .

CANCER LETTERS, 1998, 127 (1-2) :221-228

[12] Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells [J].

Hu, YL ;

Tee, MK ;

Goetzl, EJ ;

Auersperg, N ;

Mills, GB ;

Ferrara, N ;

Jaffe, RB .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (10) :762-768

[13] Functional comparisons of the lysophosphatidic acid receptors, LPA1NVZG-1/EDG-2, LPA2/EDG-4, and LPA3/EDG-7 in neuronal cell lines using a retrovirus expression system [J].

Ishii, I ;

Contos, JJA ;

Fukushima, N ;

Chun, J .

MOLECULAR PHARMACOLOGY, 2000, 58 (05) :895-902

[14] Lysophospholipid receptors: Signaling and biology [J].

Ishii, I ;

Fukushima, N ;

Ye, XQ ;

Chun, J .

ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :321-354

[15] Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells [J].

Kato, Kohei ;

Yoshikawa, Kyohei ;

Tanabe, Eriko ;

Kitayoshi, Misaho ;

Fukui, Rie ;

Fukushima, Nobuyuki ;

Tsujiuchi, Toshifumi .

TUMOR BIOLOGY, 2012, 33 (05) :1739-1744

[16] Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2 [J].

Kato, Kohei ;

Fukui, Rie ;

Okabe, Kyoko ;

Tanabe, Eriko ;

Kitayoshi, Misaho ;

Fukushima, Nobuyuki ;

Tsujiuchi, Toshifumi .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (02) :790-793

[17] Matrix Metalloproteinases: Regulators of the Tumor Microenvironment [J].

Kessenbrock, Kai ;

Plaks, Vicki ;

Werb, Zena .

CELL, 2010, 141 (01) :52-67

[18] Enhancement of endothelial cell migration by constitutively active LPA1-expressing tumor cells [J].

Kitayoshi, Misaho ;

Kato, Kohei ;

Tanabe, Eriko ;

Yoshikawa, Kyohei ;

Fukui, Rie ;

Fukushima, Nobuyuki ;

Tsujiuchi, Toshifumi .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (02) :339-343

[19] GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5 [J].

Lee, Chang-Wook ;

Rivera, Richard ;

Gardell, Shannon ;

Dubin, Adrienne E. ;

Chun, Jerold .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (33) :23589-23597

[20] Targeted Deletion of LPA5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain [J].

Lin, Mu-En ;

Rivera, Richard R. ;

Chun, Jerold .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (21) :17608-17617

← 1 2 3 4 →